Adamo, Barbara
Bellet, Meritxell
Paré, Laia
Pascual, Tomás
Vidal, Maria
Pérez Fidalgo, José A.
Blanch, Salvador
Martinez, Noelia
Murillo, Laura
Gómez-Pardo, Patricia
López-González, Ana
Amillano, Kepa
Canes, Jordi
Galván, Patricia
González-Farré, Blanca
González, Xavier
Villagrasa, Patricia
Ciruelos, Eva
Prat, Aleix
Article History
Received: 16 February 2019
Accepted: 2 September 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of Hospital Clínic de Barcelona. Reg. HCB/2015/1096. All patients provided written informed consent.
: Not applicable
: Advisory role of A.P. for Nanostring Technologies, Pierre Fabre, Roche, Pfizer, Novartis, BMS, and Roche. The other authors declare that they have no competing interests.